Skip to content

PleuraSeal Pivotal Study (US)

A Prospective Multicenter Randomized Clinical Study to Evaluate the PleuraSeal Sealant System as an Adjunct to Standard Closure Techniques for Control of Visceral Pleural Air Leaks Following Elective Pulmonary Resection Via Open Thoracotomy

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00748124
Enrollment
230
Registered
2008-09-08
Start date
2008-08-31
Completion date
2011-04-30
Last updated
2014-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Thoracotomy

Brief summary

To evaluate the safety and effectiveness of Confluent Surgical's PleuraSeal Sealant System in the treatment and control of intra and postoperative air leaks following pulmonary resection via an open thoracotomy. The performance of the PleuraSeal Sealant System as an adjunct to conventional closure techniques (i.e. surgical staples or sutures) will be compared to conventional surgical techniques alone.

Interventions

DEVICEPleuraSeal Sealant System

Lung Sealant Device + standard tissue closing techniques (sutures/staples)

Standard tissue closure techniques (sutures/ staples) alone

Sponsors

Integra LifeSciences Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective pulmonary lobectomy, segmental and/or wedge resection in one or more lobes via an open thoracotomy

Design outcomes

Primary

MeasureTime frame
Proportion of subjects remaining air leak free from time of skin closure to hospital discharge.75 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026